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Abstract
BACKGROUND—Numbers and rates of hospitalizations and ED visits by patients with COPD 
are important metrics for surveillance purposes. The objective of this study was to examine trends 
in these rates from 2001 to 2012 among adults aged ≥ 18 years in the United States.
METHODS—Data from the Nationwide Inpatient Sample (NIS) and Nationwide Emergency 
Department Sample (NEDS) were examined for temporal trends in the numbers and rates of 
hospitalizations by patients with COPD or bronchiectasis, mean length of stay, in-hospital case-
fatality rate, 30-day readmission rate, and numbers and rates of ED visits.
RESULTS—The national number of discharges with COPD or bronchiectasis as the principal 
diagnosis was about 88,000 higher in 2012 than in 2001, but the age-adjusted rate of discharges 
did not change significantly (range, 242.7-286.0 per 100,000 population, P trend = .554). In 
contrast, hospitalization rates for common cardiovascular disorders, pneumonia, and lung cancer 
decreased significantly by 27% to 68%, whereas the mean charge doubled and mean cost 
increased by 40%. From 2006 to 2011, the numbers of ED visits increased from 1,480,363 to 
1,787,612. The age-adjusted rate increased nonsignificantly from 654 to 725 per 100,000 
population (P trend = .072).
CONCLUSIONS—Despite many local and national efforts to reduce the burden of COPD, total 
hospitalizations and ED visits over the past decade have increased for COPD, and the age-adjusted 
rates of hospitalizations and ED visits for COPD or bronchiectasis have not changed significantly 
in the United States.
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COPD is an important source of morbidity and mortality despite major declines in the 
prevalence of smoking, the major cause of COPD. Because COPD lingers in most patients 
once they develop the condition, many are likely to require medical care for their condition 
during the remainder of their lifetime. National statistics from the United States suggest that 
the prevalence of COPD, the hospital discharge rate, and mortality rate may have declined 
from 2000 to 2010, whereas no clear trend was noted for the rate of ED visits.1 These results 
were derived from datasets such as the National Hospital Discharge Survey (NHDS), 
National Ambulatory Medical Care Survey (NAMCS), and National Hospital Ambulatory 
Medical Care Survey (NHAMCS), which were designed to provide national estimates but 
contain limited numbers of records.
Because of the prominence of COPD as a chronic condition and the large economic costs 
associated with this condition,2 tracking metrics such as the number and rate of 
hospitalizations and ED visits as well as readmissions among patients with COPD is critical 
to monitoring the dynamics, estimating costs, and measuring the burden of this disease. 
Therefore, the objective of this study was to examine trends in these metrics in adults using 
the largest all-payer inpatient care and ED databases that are publicly available in the United 
States.
Materials and Methods
The Healthcare Cost and Utilization Project (HCUP) comprises a series of national and 
state-level databases.3 This study used data from the Nationwide Inpatient Sample (NIS) and 
the Nationwide Emergency Department Sample (NEDS) database. This study was exempt 
from institutional review.
The NIS is created by drawing a stratified probability sample of hospitals drawn from State 
Inpatient Databases that include hospitalizations by patients with Medicare, Medicaid, 
private insurance, and the uninsured. From 2001 to 2011, the numbers of participating states 
grew from 33 to 46, the number of sampled hospitals ranged from 986 to 1,049, and the 
number of unweighted discharges ranged from 7,452,727 to 8,158,381. In 2012, 44 states, 
4,378 hospitals, and 7,296,968 discharges were included covering about 95% of the US 
population. Prior to 2012, approximately 20% of all community hospitals as defined by the 
American Hospital Association were sampled from strata created on the basis of ownership/
control, bed size, teaching status, urban/rural location, and US region, and all discharges 
from each hospital were used.4 In 2012, however, the NIS, renamed the National Inpatient 
Sample, selected a sample of 20% of all discharges from hospitals that were arranged in five 
strata.5 Hospital definitions previously based on American Hospital Association were 
changed to reflect those used by states. Sampling weights were created to produce national 
estimates. Because the NIS implemented a systematic sampling design in 2012, new 
sampling weights for trend analyses were developed.
Results for number, rate, length of stay, case-fatality rate, cost, and charge of 
hospitalizations for COPD and bronchiectasis were produced. In addition, the 30-day 
readmission rate for the years 2009 to 2012 were examined using three metrics: 
readmissions with the same International Classification of Diseases 9th Revision-Clinical 
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Modification (ICD-9-CM) codes (see later discussion in this section) as the principal 
diagnosis, readmissions with the same ICD-9-CM codes as any diagnosis, and readmissions 
for any reason. Results were limited to nonneonatal, non-maternal discharges.
Costs were calculated from charges that were billed by the hospitals using cost-to-charge 
ratios produced by the Centers for Medicare & Medicaid Services from hospital accounting 
reports. When a cost-to-charge ratio was available for a specific hospital, that ratio was used 
to estimate the cost. For other hospitals, average cost-to-charge ratios for strata defined on 
the basis of bed size, teaching status, location, ownership, and region were used.
The NEDS database, which is the largest all-payer ED database in the United States, was 
used to examine trends in the numbers and rate of ED visits from 2006 to 2011.6,7 NEDS is 
created by drawing stratified probability samples from community, nonrehabilitation 
hospitals that are part of the State Inpatient Databases and State Emergency Department 
Databases. A 20% sample is drawn from strata defined on the basis of region, trauma 
designation, urban-rural location, teaching status, and hospital ownership or control. The 
number of participating states ranged from 24 in 2006 to 30 in 2011, and the number of 
unweighted records ranged from 25.7 million in 2006 to 29.4 million in 2011. Sampling 
weights were created to produce national estimates.
The principal diagnosis listing ICD-9-CM codes that are part of the Clinical Classifications 
Software (CCS) diagnostic category 127 (COPD and bronchiectasis) was used to identify 
hospitalizations and ED visits. This category includes the following ICD-9-CM codes: 490, 
491.0, 491.1, 491.2, 491.20, 491.21, 491.22, 491.8, 491.9, 492.0, 492.8, 494, 494.0, 494.1, 
and 496. By using the principal diagnosis, confidence that the hospitalization or ED visit 
was for COPD or bronchiectasis was maximized.
To compare rates of hospitalization and ED visit for COPD and bronchiectasis with several 
other conditions, rates for acute myocardial infarction (CCS category 100 comprising 
ICD-9-CM codes 410.0, 410.00, 410.01, 410.02, 410.1, 410.10, 410.11, 410.12, 410.2, 
410.20, 410.21, 410.22, 410.3, 410.30, 410.31, 410.32, 410.4, 410.40, 410.41, 410.42, 
410.5, 410.50, 410.51, 410.52, 410.6, 410.60, 410.61, 410.62, 410.7, 410.70, 410.71, 
410.72, 410.8, 410.80, 410.81, 410.82, 410.9, 410.90, 410.91, 410.92), coronary 
atherosclerosis and other heart disease (CCS category 101 comprising ICD-9-CM codes 
411.0, 411.1, 411.8, 411.81, 411.89, 412, 413.0, 413.1, 413.9, 414.0, 414.00, 414.01, 
414.06, 414.2, 414.3, 414.4, 414.8, 414.9, V45.81, V45.82), nonhypertensive congestive 
heart failure (CCS category 108 comprising ICD-9-CM codes 398.91, 428.0, 428.1, 428.20, 
428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 
428.9), pneumonia (CCS category 122 comprising ICD-9-CM codes 003.22, 020.3, 020.4, 
020.5, 021.2, 022.1, 031.0, 039.1, 052.1, 055.1, 073.0, 083.0, 112.4, 114.0, 114.4, 114.5, 
115.05, 115.15, 115.95, 130.4, 136.3, 480.0, 480.1, 480.2, 480.3, 480.8, 480.9, 481, 482.0, 
482.1, 482.2, 482.3, 482.30, 482.31, 482.32, 482.39, 482.4, 482.40, 482.41, 482.42, 482.49, 
482.8, 482.81, 482.82, 482.83, 482.84, 482.89, 482.9, 483, 483.0, 483.1, 483.8, 484.1, 
484.3, 484.5, 484.6, 484.7, 484.8, 485, 486, 513.0, 517.1), and lung cancer (CCS category 
19 comprising ICD-9-CM codes 162.2, 162.3, 162.4, 162.5, 162.8, 162.9, 209.21, 231.2, 
V10.11) were calculated.
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The online query system HCUPnet (http://hcupnet.ahrq.gov/) was used to generate data for 
this analysis.8 Analyses were limited to adults aged ≥ 18 years. Revised sampling weights 
that were produced as part of the 2012 redesign were used to generate national estimates for 
measures related to hospital discharges. Direct age adjustment to the projected year 2000 US 
population was performed using four age groups (18-44 years, 45-64 years, 65-84 years, and 
≥ 85 years). Weighted least-squares regression was used to perform tests of linear trend for 
possible trends of the outcomes of interest. The online query system used the software 
SUDAAN (Research Triangle Institute) to generate SEs.
Results
The weighted number of hospital discharges for COPD and bronchiectasis ranged from 
534,398 to 692,364 (Fig 1). Of the numbers of combined COPD and bronchiectasis 
hospitalizations, 98.1% to 98.6% were for COPD (ICD-9 codes 490, 491, 492, 496). The 
average annual number of discharges was about 100,000 higher from 2008 to 2012 than 
from 2001 to 2007. The age-adjusted rate of discharges ranged from 242.7 to 286.0 per 
100,000 population and showed no clear trend (P trend = .554) (Table 1). Significant 
decreases were noted for participants aged 18 to 44 years and 65 to 84 years, whereas a 
significant increase was noted for those aged 45 to 64 years. The mean length of stay 
decreased overall and in all age groups except in the youngest adults. The age-adjusted case-
fatality rate dropped from 2.5% to 1.1%, and significant decreases occurred in all age 
groups. In contrast to COPD and bronchiectasis, the age-adjusted rates for discharges for 
acute myocardial infarction (P trend < .001), coronary atherosclerosis and other heart 
disease (P trend < .001), congestive heart failure (P trend < .001), pneumonia ( P trend < .
001), and lung cancer (P trend < .001) declined significantly (Fig 2).
Aggregate charges for inpatient stays increased progressively from $8,023,983,422 in 2001 
to $18,112,392,566 in 2012 (Fig 3) as did the mean and median charge per inpatient stay 
(Table 1). Mean and median costs increased as well but less sharply than charges.
The numbers of ED visits increased steadily from about 1,480,363 in 2006 to 1,787,612 in 
2011 (Table 2). The age-adjusted rate increased mildly, driven by a significant increase in 
the rate among adults aged 45 to 64 years. Of those who had an ED visit, about 19% to 21% 
of these patients were admitted to the hospital. The age-specific mortality in the ED ranged 
from 0.1% to 0.3%.
Compared with COPD and bronchiectasis, the age-adjusted rate of ED visits declined for 
acute myocardial infarction (P trend = .002), coronary atherosclerosis and other heart 
disease (P trend < .001), congestive heart failure (P trend = .001), pneumonia (P trend = .
044), and lung cancer (P trend < .001) (Fig 4).
Of patients with an index diagnosis of COPD or bronchiectasis, about 7% were readmitted 
within 30 days with COPD or bronchiectasis as the principal diagnosis, 18% were 
readmitted within 30 days with COPD or bronchiectasis listed as any diagnosis, and 21% 
were readmitted within 30 days for any reason (Table 3). The most recent estimates from 
2012 suggested some improvement in readmission rates.
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Discussion
The current study, which provides the most up-to-date statistics, shows no significant trend 
in the age-adjusted rates of hospital discharges from 2001 to 2012 or ED visits from 2006 to 
2011 for COPD or bronchiectasis. The persistence of these rates in the face of large declines 
in the prevalence of smoking is a bit perplexing but underscores the protracted nature of 
COPD. Significantly decreasing trends were found for mean length of stay and for the in-
hospital case-fatality rate.
The lack of declining trend in the rate of hospital discharges in the NIS data contrasts with 
results from the NHDS that showed a decline in the age-adjusted rate from 402 per 100,000 
in 1999 to 322 per 100,000 population in 2010. If 2001 is used as a starting point, however, 
the rate declined from 366 to 322 per 100,000 population in 2010.1 It is noteworthy that the 
age range in the NHDS analysis was ≥ 25 years compared with ≥ 18 years in the present 
study. The lack of a significant trend in the age-adjusted rate of ED visits agrees with results 
from the NHAMCS.1
The present study found a decline in mean length of stay from 4.5 days in 2001 to 4.0 days 
in 2012 among patients hospitalized for COPD or bronchiectasis. Limited information on 
temporal trends in length of stay among US patients with COPD has been published. In 
greater metropolitan Cleveland, Ohio, the mean length of stay for COPD hospitalizations 
decreased from 7.5 days in 1991 to 5.4 days in 1997.9 These declines could be due to 
improved outpatient and inpatient treatment, less severe forms of the disease, and pressures 
to reduce the costs of hospitalizations.
The NIS data showed a substantial decline in the in-hospital case-fatality rate from 2001 to 
2012. A few reports have previously examined temporal changes in the in-hospital case-
fatality rate in the United States. Data from the US Veterans Administration system showed 
that the in-hospital case-fatality rate among patients with COPD rose from 4.3% in 1970 to 
7.9% in 1987.10 In greater metropolitan Cleveland, the unadjusted in-hospital mortality rate 
following a hospitalization for COPD among Medicare patients decreased by 49.6% from 
1991 to 1997.9 Adjusted in-hospital and 30-day mortality rates decreased by 53.7% and 
26%, respectively. The reasons for the large decline in the in-hospital case-fatality rate for 
hospitalizations for COPD or bronchiectasis could be due to improved treatment or to less 
severe forms of the disease. Some of the decline may also be attributable to the decrease in 
the mean length of stay.
Rates of hospitalizations and ED visits are a reflection of the numbers of adults with COPD 
or bronchiectasis and, once someone has the condition, utilization of health-care services. 
Therefore, declines in the rates can be accomplished by reducing the numbers of adults who 
have COPD, by reducing the need for hospitalizations once an adult has developed COPD, 
or a combination of the two. Favorable trends in the prevalence of smoking and in air 
pollution should eventually reduce the prevalence of COPD.11,12 Although limited evidence 
points to a possible decline in the prevalence of COPD since 1999, the prevalence of self-
reported COPD remains stubbornly high.1 Among patients with COPD or obstructive lung 
function, the prevalence of smoking has remained very high.13,14 Therefore, increased 
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efforts to promote smoking cessation in these patients may reduce their hospitalizations and 
visits to the emergency room. In addition, annual vaccinations for influenza, vaccinations for 
pneumococcal disease, and optimal management of their condition including pulmonary 
rehabilitation should also reduce this need.
Reducing readmissions has become an important objective of medical care in recent times.15 
Only 4 years of NIS data about the readmission rate in patients hospitalized for COPD or 
bronchiectasis were available, and these results showed mostly little change in the 30-day 
readmission rate during that time, with about 7% of patients with COPD or bronchiectasis 
being readmitted within 30 days with COPD or bronchiectasis as the principal diagnoses 
although the results for 2012 hinted at some improvement. Previous studies have reported 
30-day read-mission rates among Medicare beneficiaries with COPD of 22.6% from 2003 to 
2004 and of 7.1% for COPD as the principal diagnosis, 17.3% for any diagnosis of COPD, 
and 20.5% for any diagnosis in 2008.16,17 A host of patient, clinical, provider, and system 
factors have been found to predict readmissions among patients with COPD.18-28 
Interventions to reduce readmissions have met with mixed success, but some that may 
reduce readmissions include continuity with patient's primary care provider or 
pulmonologist,29 coordination of discharges,30 and pulmonary rehabilitation.31 However, 
the time frame for examining the rate of readmissions following these interventions was as 
long as 1 year rather than 30 days.
Several limitations warrant consideration. Because data for the present study were obtained 
by using an online research tool, stratification by other factors such as demographic factors 
was not feasible. Second, severity of the condition that led a patient to access medical care 
was not available, and, therefore, the possible contribution of changes in disease severity to 
changes in length of stay and case-fatality rate could not be examined. Third, the validity of 
the ICD-9-CM codes used to identify hospitalizations and ED visits for COPD and 
bronchiectasis in the NIS and NEDS has not been specifically tested. Limited studies of 
hospitalizations in other settings have shown sensitivities of 55% to 65%, specificities of 
67% to 90%, and a positive predictive value of 50.4%.32,33 In addition, a study of ED 
records showed positive predictive values ranging from 60% to 100% depending on the 
ICD-9 code.34
In conclusion, data from the NIS show that rates of hospital discharges from 2001 to 2012, 
ED visits from 2006 to 2011, and 30-day readmission rate from 2009 to 2012 among 
patients with COPD or bronchiectasis changed nonsignificantly. In contrast, significant 
reductions in length of stay and case-fatality rate occurred in the hospital. These results 
should serve to inform efforts to optimize medical care for patients with COPD or 
bronchiectasis in the United States.
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Figure 1. 
Numbers of hospital discharges for COPD or bronchiectasis among patients aged ≥ 18 y, 
Nationwide Inpatient Sample 2001-2012.
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Figure 2. 
Age-adjusted rate of hospitalizations for selected chronic conditions among patients aged ≥ 
18 y, Nationwide Inpatient Sample 2001-2012. AMI = acute myocardial infarction; B = 
bronchiectasis; CA = coronary atherosclerosis; CHF = congestive heart failure; OHD = other 
heart disease.
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Figure 3. 
Aggregate charges for inpatient stays for COPD or bronchi-ectasis among patients aged ≥ 18 
y, Nationwide Inpatient Sample 2001-2012.
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Figure 4. 
Age-adjusted rate of ED visits for selected chronic conditions among patients aged ≥ 18 y, 
Nationwide Emergency Department Sample 2006-2011. See Figure 2 legend for expansion 
of abbreviations.
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Table 3
Unadjusted Percentage of Readmission Within 30 d Among Patients Aged ≥ 18 y With an Index 
Hospitalization for COPD or Bronchiectasis, Nationwide Inpatient Sample 2009-2012
Readmissions 2009 2010 2011 2012
Readmissions with the same ICD-9-CM codes as principal diagnosis
    Total 7.4 7.1 7.3 6.9
    Age group, y
        18-44 5.8 5.2 5.2 4.8
        45-64 8.4 8.0 8.2 7.9
        65+ 7.0 6.7 6.9 6.5
Readmissions with the same ICD-9-CM in any diagnosis
    Total 18.0 17.7 18.1 17.5
    Age group, y
        18-44 10.9 10.6 10.9 10.8
        45-64 17.5 17.2 17.7 17.1
        65+ 18.7 18.4 18.7 18.0
Readmissions for any cause
    Total 21.2 20.9 21.2 20.5
    Age group, y
        18-44 16.4 16.5 17.1 16.6
        45-64 21.0 20.7 21.1 20.5
        65+ 21.6 21.1 21.4 20.7
ICD-9-CM = International Classification of Diseases 9th Revision-Clinical Modification.
Chest. Author manuscript; available in PMC 2016 April 01.
